From professional translators, enterprises, web pages and freely available translation repositories.
(abl.
(abl.
Last Update: 2014-10-23
Usage Frequency: 13
Quality:
geni abl
abl-gener
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
bcr-abl 20
bcr- abl 20
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
juni 1999 (abl.
juni 1999 (abl.
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
september 1999, abl.
september 1999, abl.
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
februar 2004 (abl.
februar 2004 (abl.
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
proteina oncogena v-abl
onkogenproteiner v-abl
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
proteine di fusione bcr-abl
fusionsproteiner, bcr-abl
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
leucemia mielogena cronica bcr-abl positiva
leukemi, myeloid, kronisk, bcr-abl positiv
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
c 100 vom 27.3.1997, s. 12; abl.
c 100 vom 27.3.1997, s. 12; abl.
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
juni 1999 mit allgemeinen bestimmungen über die strukturfonds (abl.
juni 1999 mit allgemeinen bestimmungen über die strukturfonds (abl.
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
[10] abl. c 19 vom 20.1.2001, s. 7
[10] abl. c 19 vom 20.1.2001, s. 7
Last Update: 2008-03-04
Usage Frequency: 13
Quality:
Reference:
[1] abl. l 83 vom 27.3.1999, s. 1.
[1] abl. l 83 vom 27.3.1999, s. 1.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Reference:
si lega ad entrambe le conformazioni attiva e non attiva dell' enzima bcr-abl.
den binder till både inaktiva och aktiva konformationer av bcr- abl- enzymet.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
nilotinib agisce bloccando la protein chinasi chiamata chinasi “ bcr-abl”.
(44- 20) 74 18 84 00 fax (44- 20) 74 18 84 16 e- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©emea 2007 reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the emea is acknowledged produceras av leukemiceller och får dem att föröka sig okontrollerat.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
in vivo il composto evidenzia una attività antitumorale come agente singolo nei modelli animali con cellule tumorali positive a bcr-abl.
in vivo uppvisar ämnet anti- tumöraktivitet givet som enda agens i djurmodeller med bcr- abl- positiva tumörceller.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Reference:
c 277, 14.11.2002, s. 2; n 383/2002 neorion shipyards, abl.
c 277, 14.11.2002, s. 2; n 383/2002 neorion shipyards, abl.
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
Reference:
sprycel aiuta a controllare la moltiplicazione delle cellule leucemiche inibendo, insieme ad altre chinasi, la chinasi bcr-abl.
genom att hämma bcr - abl- kinaset, liksom andra kinaser, hjälper sprycel till att kontrollera spridningen av leukemiceller.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Reference:
[11] abl. c 100 vom 27.3.1997, s. 12; abl. c 260 vom 17.9.1994, s. 3
[11] abl. c 100 vom 27.3.1997, s. 12; abl. c 260 vom 17.9.1994, s. 3
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Reference: